Abnormal Sialylation Promotes Chemotherapy Resistance in Bladder Cancer via the PI3K-AKT-mTOR Signaling Pathway. Zhu J, Wang A, Tong H, Sun Y, et al. Cancers (Basel) 2026;18:1713.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhu J, Wang A, Tong H, Sun Y, et al. Abnormal Sialylation Promotes Chemotherapy Resistance in Bladder Cancer via the PI3K-AKT-mTOR Signaling Pathway. Cancers (Basel) 2026;18:1713.
PMID: 42279297